ArticleDocumenta ophthalmologica. Advances in ophthalmology2026
Assessment of full-field stimulus test results in Stargardt disease: correlations with full-field electroretinography, multifocal electroretinography, and optical coherence tomography.
Article in Documenta ophthalmologica. Advances in ophthalmology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeThe aim of this study is to evaluate the results of the Full-Field Stimulus test (FST) in patients with Stargardt disease (STGD), and to compare these results with findings obtained from other ophthalmologicalassesments.
methodsTwenty-six eyes with STGD and 26 eyes from healthy controls were included in the study. Following a routine ophthalmologic examination, all participants underwent optical coherence tomography, full-field and multifocal electroretinography, and full-field stimulus testing.
resultsThe mean age was 29.3 years in the STGD group and 27.1 years in the control group. All participants successfully completed the FST procedure. Visual acuity and central macular thickness were significantly lower in the STGD group compared to the control group (p < 0,01). Multifocal electroretinography (mfERG) analysis revealed significantly decreased mean P1-wave amplitudes and prolonged mean P1-wave implicittimes across all rings in the STGD group. Additionally, FST threshols for white, blue and red stimuli were significantly lower in the STGD group than in the control group (p < 0,01). Correlation analysis revealed a positive relationship between FST results and visual acuity, mfERG amplitudes and central macular thickness.
conclusionFST is a simple, reliable and rapid test that can be applied in patients with low visual acuity. It effectively measures retinal sensitivity in patients with STGD. Given its practicality FST can be safely used to monitor the disease progression and treatment response in inherited retinal diseases.
Indexed as
Identifiers
42541666What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.